These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 9677468

  • 1. Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma.
    Linder C, Linder S, Munck-Wikland E, Strander H.
    Anticancer Res; 1998; 18(3B):2063-8. PubMed ID: 9677468
    [Abstract] [Full Text] [Related]

  • 2. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients.
    Brattström D, Bergqvist M, Larsson A, Holmertz J, Hesselius P, Rosenberg L, Brodin O, Wagenius G.
    Anticancer Res; 1998; 18(2A):1123-7. PubMed ID: 9615776
    [Abstract] [Full Text] [Related]

  • 3. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C, Coudert MC, Lepage E, Cabane J, Richard F.
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [Abstract] [Full Text] [Related]

  • 4. Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours.
    Komorowski J, Jankewicz J, Stepień H.
    Cytobios; 2000 Dec; 101(398):151-9. PubMed ID: 10755214
    [Abstract] [Full Text] [Related]

  • 5. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
    Aguayo A, Kantarjian HM, Estey EH, Giles FJ, Verstovsek S, Manshouri T, Gidel C, O'Brien S, Keating MJ, Albitar M.
    Cancer; 2002 Nov 01; 95(9):1923-30. PubMed ID: 12404286
    [Abstract] [Full Text] [Related]

  • 6. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
    Tabone MD, Landman-Parker J, Arcil B, Coudert MC, Gerota I, Benbunan M, Leverger G, Dosquet C.
    Clin Cancer Res; 2001 Mar 01; 7(3):538-43. PubMed ID: 11297245
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A, Weindel K, Ochs A, Marth C, Zmija J, Schumacher P, Unger C, Marmé D, Gastl G.
    Cancer; 1999 Jan 01; 85(1):178-87. PubMed ID: 9921991
    [Abstract] [Full Text] [Related]

  • 8. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis.
    Tamura M, Ohta Y.
    Cancer; 2003 Sep 15; 98(6):1217-22. PubMed ID: 12973845
    [Abstract] [Full Text] [Related]

  • 9. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors.
    Holzer G, Obermair A, Koschat M, Preyer O, Kotz R, Trieb K.
    Med Pediatr Oncol; 2001 Jun 15; 36(6):601-4. PubMed ID: 11344490
    [Abstract] [Full Text] [Related]

  • 10. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
    Robak E, Woźniacka A, Sysa-Jedrzejowska A, Stepień H, Robak T.
    Eur Cytokine Netw; 2001 Jun 15; 12(3):445-52. PubMed ID: 11566625
    [Abstract] [Full Text] [Related]

  • 11. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.
    Salgado R, Vermeulen PB, Benoy I, Weytjens R, Huget P, Van Marck E, Dirix LY.
    Br J Cancer; 1999 May 15; 80(5-6):892-7. PubMed ID: 10360671
    [Abstract] [Full Text] [Related]

  • 12. [Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in superficial transitional cell bladder carcinoma].
    Guo ZH, Mei H, Huang J, Li SY.
    Ai Zheng; 2003 Mar 15; 22(3):307-9. PubMed ID: 12654193
    [Abstract] [Full Text] [Related]

  • 13. Elevated vascular endothelial growth factor levels in sera of patients with lung cancer.
    Takigawa N, Segawa Y, Fujimoto N, Hotta K, Eguchi K.
    Anticancer Res; 1998 Mar 15; 18(2B):1251-4. PubMed ID: 9615796
    [Abstract] [Full Text] [Related]

  • 14. Angiogenic factors: vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) are not necessarily elevated in patients with advanced renal cell carcinoma.
    Edgren M, Lennernäs B, Larsson A, Kälkner KM.
    Anticancer Res; 2001 Mar 15; 21(2B):1423-9. PubMed ID: 11396226
    [Abstract] [Full Text] [Related]

  • 15. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
    Shang ZJ, Li JR, Li ZB.
    Int J Oral Maxillofac Surg; 2002 Oct 15; 31(5):495-8. PubMed ID: 12418564
    [Abstract] [Full Text] [Related]

  • 16. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F, Azzaro MP, Palumbo G, Bagnato S, Giustolisi G, Floridia P, Sortino G, Giustolisi R.
    Haematologica; 2000 Aug 15; 85(8):800-5. PubMed ID: 10942925
    [Abstract] [Full Text] [Related]

  • 17. A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis.
    Braybrooke JP, O'Byrne KJ, Propper DJ, Blann A, Saunders M, Dobbs N, Han C, Woodhull J, Mitchell K, Crew J, Smith K, Stephens R, Ganesan TS, Talbot DC, Harris AL.
    Clin Cancer Res; 2000 Dec 15; 6(12):4697-704. PubMed ID: 11156222
    [Abstract] [Full Text] [Related]

  • 18. Early increase in serum levels of the angiogenesis-inhibitor endostatin and of basic fibroblast growth factor in melanoma patients during disease progression.
    Kurschat P, Eming S, Nashan D, Krieg T, Mauch C.
    Br J Dermatol; 2007 Apr 15; 156(4):653-8. PubMed ID: 17263813
    [Abstract] [Full Text] [Related]

  • 19. Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver mestastasis vascularity and volume.
    Davies MM, Jonas SK, Kaur S, Allen-Mersh TG.
    Br J Cancer; 2000 Mar 15; 82(5):1004-8. PubMed ID: 10737380
    [Abstract] [Full Text] [Related]

  • 20. Expression of vascular endothelial growth factor and basic fibroblast growth factor in small adenocarcinomas.
    Ito H, Oshita F, Kameda Y, Suzuki R, Ikehara M, Arai H, Mitsuda A, Saito H, Yamada K, Noda K, Nakayama H.
    Oncol Rep; 2002 Mar 15; 9(1):119-23. PubMed ID: 11748468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.